The WHO recommends preventive treatment for all pediatric contacts of a confirmed TB case, but coverage remains low in many high TB burden countries. We aimed to assess the coverage and adherence of the isoniazid preventive therapy (IPT) program among children under 5?years of age with household exposure to an adult pulmonary TB case in a rural district of Southern Mozambique. The estimated IPT coverage was 11.7%. A longer distance to the health center and lower age of the children hindered IPT initiation. Among patients who started IPT, 12/18 (69.9%) were adherent to the 6-month treatment. © The Author(s) [2023]. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
SETTING: We compared the change in child household contact management of pulmonary tuberculosis (TB)...
Background: Tuberculosis (TB) is a leading cause of death in HIV-positive children in sub-Saharan Af...
<div><p>A child’s risk of developing tuberculosis (TB) can be reduced by nearly 60% with administrat...
Background. The World Health Organization recommends that all children below the age of five who hav...
A child's risk of developing tuberculosis (TB) can be reduced by nearly 60% with administration of 6...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
Introduction: Tuberculosis is the second leading cause of death from an infectious cause worldwide h...
OBJECTIVE: To assess adherence to isoniazid preventive therapy (IPT) in children exposed to adult pu...
Background. Tuberculosis (TB) is a significant contributor to the international and national burden ...
Hawassa, Southern Region of Ethiopia.To determine compliance to isoniazid (INH) preventive therapy (...
Background Isoniazid Preventative Therapy (IPT) is recommended for children aged less than 5 years t...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
Background: Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chem...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
SETTING: We compared the change in child household contact management of pulmonary tuberculosis (TB)...
Background: Tuberculosis (TB) is a leading cause of death in HIV-positive children in sub-Saharan Af...
<div><p>A child’s risk of developing tuberculosis (TB) can be reduced by nearly 60% with administrat...
Background. The World Health Organization recommends that all children below the age of five who hav...
A child's risk of developing tuberculosis (TB) can be reduced by nearly 60% with administration of 6...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
Introduction: Tuberculosis is the second leading cause of death from an infectious cause worldwide h...
OBJECTIVE: To assess adherence to isoniazid preventive therapy (IPT) in children exposed to adult pu...
Background. Tuberculosis (TB) is a significant contributor to the international and national burden ...
Hawassa, Southern Region of Ethiopia.To determine compliance to isoniazid (INH) preventive therapy (...
Background Isoniazid Preventative Therapy (IPT) is recommended for children aged less than 5 years t...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
Background: Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chem...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
BACKGROUND AND OBJECTIVE: Isoniazid preventive therapy (IPT) is known to reduce the risk of developi...
SETTING: We compared the change in child household contact management of pulmonary tuberculosis (TB)...
Background: Tuberculosis (TB) is a leading cause of death in HIV-positive children in sub-Saharan Af...